masct:multiple antigens specific cellular therapy

Cell therapyexperimental

Clinical trial activity

6 trials · 11 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2013 (NCT02026362)

Timeline

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2024

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • masct:multiple antigens specific cellular therapy

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06277154Phase 2Feb 29, 2024HRYZ Biotech Co., Sun Yat-Sen University
NCT04904185Phase 1Aug 17, 2021Technical University of Denmark, University of Copenhagen
NCT05877651Phase 1Apr 21, 2020HRYZ Biotech Co., Sun Yat-Sen University
NCT03393416Phase 1Jan 31, 2018Chinese Academy of Medical Sciences, SYZ Cell Therapy Co..
NCT02858232Phase 1/Phase 2 (Phase 2)Aug 1, 2016Hengrui Therapeutics, Inc., The First People's Hospital of Lianyungang
NCT02026362Phase 1/Phase 2 (Phase 2)Jul 1, 2013Fujian Medical University, People's Liberation Army of China, Southern Medical University, Sun Yat-Sen University, SYZ Cell Therapy Co..
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Sun Yat-Sen UniversityAcademic/Hospital3022013
HRYZ Biotech Co.For profit2222020
SYZ Cell Therapy Co..For profit2222013
Chinese Academy of Medical SciencesAcademic/Hospital1012018
Fujian Medical UniversityAcademic/Hospital1012013
Hengrui Therapeutics, Inc.For profit1012016
People's Liberation Army of ChinaGovernment1012013
Southern Medical UniversityAcademic/Hospital1012013
Technical University of DenmarkAcademic/Hospital1012021
The First People's Hospital of LianyungangAcademic/Hospital1112016
University of CopenhagenAcademic/Hospital1112021
11 organizations
Page 1 / 1